Bharat Biotech to Commence Covaxin Production in Bhubaneswar from June ‘22
The Odisha Government has announced that the construction work for a vaccine production unit has been started at the outskirts of Andharua in Bhubaneswar, with an initial target to commence full-fledged Covaxin production by June next year. Covaxin, developed and marketed by Hyderabad-based Bharat Biotech, is one of the many vaccines approved for use in India today.
The announcement transpired post the conclusion of a high-level Bio-Tech implementation committee meeting, presided by Chief Secretary Suresh Chandra Mahapatra. Mahapatra has ordered officials to ensure that project deadlines are met and reiterated the government’s desire to see vaccine production commence at the Andharua unit by June 2022. He also advised the department to establish a separate, professional Directorate of Bio-Technology to concentrate on the incubation of new industries in the sector.
The newly built unit will also manufacture ten types of advanced vaccines, including Covaxin and an anti-malarial antidote. “Smooth land allotment process by the IDCO [Odisha Industrial Infrastructure Development Corporation] and ‘ease of doing business’ reforms have helped in beginning the process,” Mahapatra said. He also highlighted that all necessary governmental clearances have been issued for the project.
“The government has made provisions for extending different incentives to biotech incubation and startups in form of land allotment, exemption of stamp duty, land conversion, training subsidy, capital investment subsidy, interest subsidy etc. under the Odisha Biotechnology Policy of 2018. Around Rs 15 crore was allocated under the ‘Fund of Funds’ of MSME department for providing equity support to the incubating units in the Biotechnology sector,” said Secretary Science and Technology Manoj Mishra, who also attended the meeting.
Sanjay Singh, Chairman and Managing Director of IDCO, said that a state-of-the-art incubation facility with over 28,000 square feet of space and comprising of two levels has come up near Infocity. He said the decision will benefit around 775 startups in Odisha, of whom 65 have already acquired patents, trademarks and copyrights.